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Background. Patients with end-stage renal failure have high rates of cardiovascular morbidity and mortality. It is not clear yet
whether it is the hemodialysis procedure or the uremia itself that is the major determinant of this increased risk. We set out to
determinewhether atherosclerosis wasmore accelerated in patients with uremia at the initiation of chronic hemodialysis therapy
compared with that in a control group of those without uremia who had a similar cardiovascular risk profile. Also, risk factors
related to premature atherosclerosis were investigated.
Patients and Methods. High-resolution B-mode ultrasonography was used to determine the intima-media thickness (IMT) of
the carotid arteries in 30 patientswith uremia just before the initiation of chronic hemodialysis therapy and in 26 controlswithout
uremia.
Results. The 2 groups were similar in age, sex, presence of hypertension, presence of dyslipidemia, and smoking habits. Serum
levels of total cholesterol, triglycerides, total HDL, fibrinogen, inorganic phosphorus, and total calciumwere evaluated. The IMT
values of the patients with uremia were significantly higher than were those of the control group. The patients with uremia had
higher levels of serumfibrinogen, inorganic phosphorus, and triglycerides. The IMTvalues significantly correlatedwith age,male
sex, and triglyceride level in the patients with uremia. In the control group, only age showed a significant correlation with IMT
values.
Conclusion. These results indicate that patientswith uremia at the initiation of chronic hemodialysis therapy hadhigher carotid
IMT values than did a control group of those without uremia who have a similar cardiovascular risk profile. Thus, uremic status
per se may be responsible for the increased risk of premature atherosclerosis. Identification of a positive correlation between
carotid IMT and triglyceride levels may indicate that therapeutic interventions are necessary to reduce this risk.
B
ecause patients with end-
stage renal failure have high
rates of cardiovascular mor-
bidity and mortality, early detection
and prevention of atherosclerosis is
important.1,2 It is not clear yet
whether it is the hemodialysis (HD)
procedure or uremia itself that is the
major determinant of this increased
risk. In early studies it was found that
prolonged HD accelerated athero-
sclerosis.3 However, patients with
uremia are also known to have
atherosclerotic cardiovascular
events even in the predialytic stage.4
Thus, determination of early athero-
sclerosis and the relevant risk factors
before the initiation of chronic HD
therapy is important for the develop-
ment of treatment and/or prevention
strategies.
High-resolution B-mode ultraso-
nography is used in the noninvasive
evaluation of early atherosclerosis in
superficial arteries.6,7 With the help
of this technique, even in the absence
of discrete plaque or stenosis, the
combined thicknesses of the arterial
intima and media can be measured
with considerable precision.8 Intima-
media thickness (IMT) is accepted as
being associated with the early phase
of atherosclerosis.9 It was demon-
strated that vascular changes in
carotid arteries reflect general ather-
osclerosis10 and have a strong asso-
ciation with coronary status.11
The aim of this study was to
determine whether atherosclerosis
was more accelerated in patients
with uremia just before initiation of
chronic HD therapy compared to a
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control group of those without ure-
mia but with a similar cardiovascular
risk profile. Also, risk factors related
to premature atherosclerosis were
investigated.
Methods
Subjects
The participants in the study were
divided into 2 groups. The first group
was composed of 30 patients with
uremia who were at the stage of
initiation of chronic HD therapy
(mean age SD: 52.33 8.18 years,
range 40–70 years), and the second
group was composed of 26 control
subjects who did not have uremia
(mean age SD: 54.42 9.15 years,
range 40–68 years). In the uremic
group, 21 patients were hypertensive
and 9 were normotensive. In the
nonuremic control group, 18 subjects
were hypertensive and 8 were nor-
motensive.
Those with diabetes mellitus,
nephrotic syndrome, vasculitis, per-
ipheric and cerebrovascular disease,
or secondary hypertension—which
are additional risk factors—were
excluded. In addition, subjects with
clinicallymanifest and/or a history of
coronary artery disease alsowere not
included. The nonuremic control
subjects were classified as having
normal kidney function on the basis
of normal values of blood urea
nitrogen and creatinine and a normal
urine analysis.
The serum glucose, creatinine,
total cholesterol, triglycerides, total
HDL cholesterol, total calcium, inor-
ganic phosphorus, fibrinogen, body
surface area (BSA), and body mass
index (BMI) of all subjects were
evaluated. Other laboratory investi-
gations included hemogram, urine
analysis, abdominal ultrasonogra-
phy, and creatinine clearance. Crea-
tinine clearance was calculated
according to the Cockcroft and
Gault formula; CG-GFR (mL/min):
[{(140age [years])lean body
weight [kg]}/{serum creatinine
72}](0.85 if female).
All patients in the uremic group
had a creatinine clearance less than
10mL/min (mean SD: 6.39
1.95mL/min); additionally, they
had high serum creatinine levels
(mean SD: 11.52 2.55mg/dL). In
abdominal ultrasonography grade 3
or grade 4 renal parenchymal disease
and decreased kidney size were
observed. Other laboratory findings
of the uremic subjects were also
consistent with end-stage renal fail-
ure. Blood pressure was measured
from the right arm after 10minutes of
rest in the supine position. Results
were determined as the average of
three measurements. Hypertension
was diagnosed if a subject had
received antihypertensive agents or
had a systolic pressure of 160 mmHg
or greater and/or a diastolic pressure
of 95 mHg or greater.
For patients on antihypertensive
treatment, the number and types
of antihypertensive drugs were
recorded. The presence of dyslipide-
mia was diagnosed if a subject was
taking antilipidemic agents and/or if
serum cholesterol was greater than
200mg/dL, total HDL cholesterol
was less than 35mg/dL, or triglycer-
ides were greater than 200mg/dL.
Exposure to cigarettes was evaluated
in package-years, which was the
product of years smoked times the
number of package consumed daily.
Ultrasonography
Ultrasonographicinvestigationswere
performed with a Hitachi EUB 420
high-resolution B-mode ultrasono-
graphy system (Hitachi Medical
Corp., Tokyo, Japan). A 4-cm-long,
7.5-mHz linear transducer was used.
All examinations were carried out by
the same operator. Measurement of
IMT of the bilateral common carotid
artery was performed at 10, 20, and
30mm proximal to the bifurcation in
the anterior oblique lateral and pos-
terior oblique longitudinal views
during end diastole and on the far
wall of the artery between the lumen-
intima and media-lumen interfaces.6
No measurement was made on sites
where a plaque existed. The mean of
the 18 IMTmeasurements was calcu-
lated, and thiswas defined as the IMT
of the common carotid artery.
Statistical Analysis
All analyseswere carried outwith the
SPSS-PC statistical package. The
Student’s t-test, chi-square test, two-
way ANOVA, multiple regression
analysis, and correlation analysis
were used. Data are expressed as
means SD. A p value <0.05 was
considered statistically significant.
Results
A comparison of the demographic
and clinical characteristics of the
subjects with uremia and the control
subjects without uremia showed the
2 groups to be similar in age, sex,
BSA, presence of hypertension, sys-
tolic and diastolic blood pressures,
smoking habits, and presence of
dyslipidemia. In the patients with
uremia, serum triglycerides, fibrino-
gen, and phosphorus levels were
significantly higher than in the con-
trols. The control group had signi-
ficantly higher BMI and total
cholesterol level compared with
those of the patients with uremia. In
patients who were on antihyperten-
sive treatment, the number and over-
all distribution of antihypertensive
drugs did not differ significantly.
However, the duration of hyperten-
sion was longer in the control group
(Tables I and II).
The carotid IMT of the patients
with uremia was significantly in-
creased compared with that in the
controls: 1.17 0.19mm versus
1.03 0.15mm, p < 0.01 (Figure 1).
Among all the variables, age and
triglycerides were found to be posi-
tively correlated with carotid IMT in
the patients with uremia. In the
controls, only age was found to be
positively correlated with carotid
IMT (Table III).
In the group of patients with
uremiamale sex, not female sex, was
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shown to increase carotid IMT. How-
ever, both male and female patients
with uremia had greater carotid IMT
values than did the controls without
uremia. When the subjects with
dyslipidemia were considered, those
with uremia had greater carotid IMT
values than did the controls. The
presence of dyslipidemia was shown
to increase carotid IMT values in
those with uremia. Cigarette smok-
ing was found not to affect carotid
IMT values. When the subjects with
and without hypertension were con-
sidered, the patients with uremia had
greater carotid IMT values than did
the controls. Having hypertension
was shown not to affect carotid IMT
values, both in the patients with
uremia and in the controls (Table IV).
Multiple regression analysis tak-
ing all the continuous cardiovascular
risk parameters into account showed
that age and triglycerides contributed
significantly to the carotid IMT in the
group of those with uremia, whereas
only age was significantly contribu-
ted to the carotid IMT in the control
group (Tables V and VI).
Discussion
In the present study, carotid IMTwas
determined in patients with uremia
just before the initiation of chronic
HD therapy and in control subjects,
without uremia and similar both in
demographic features and, most im-
portant, in cardiovascular risk pro-
file. Such a study design is important
to determine the influence on athero-
sclerosis of uremia itself, rather than
the conventional cardiovascular risk
factors, which are well known to be
found abundantly in uremic patients.
We detected a significant increase
in the carotid IMT of patients with
uremia compared with that in the
nonuremic control group, indicating
that atherosclerosis was more accel-
erated in the presence of uremia.
Our results also suggest that athero-
genic factors are already operative
even before the initiation of chro-
nic HD therapy. It was previously
Table I. Clinical characteristics of the study patients.
Uremic Group Nonuremic Group
(n¼ 30) (n¼ 26)
age 52.33 8.18 54.42 9.15
BMI (kg/m2)* 24.29 3.68 27.63 5.02
BSA (m2) 1.65 0.16 1.74 0.21
glucose (mg/dL) 88.00 9.28 88.19 9.93
total cholesterol (mg/dL){ 174.98 49.21 204.00 47.57
triglyceride (mg/dL){ 187.41 74.64 145.23 54.93
total HDL cholesterol (mg/dL) 44.20 7.57 44.96 7.03
total calcium (mmol/L) 1.96 0.38 2.07 0.44
inorganic phosphorus (mmol/L)z 2.16 0.50 1.22 0.28
systolic blood pressure (mmHg) 137.97 15.32 136.23 16.41
diastolic blood pressure (mmHg) 85.36 10.57 85.80 18.90
hypertension duration (mo)* 21.61 13.55 34.77 10.97
fibrinogen (g/L)* 3.84 1.15 3.08 0.89
cigarette (package-years) 21.85 17.86 17.45 9.56
*p<0.01
{p<0.05
zp<0.001
BMI¼body mass index, BSA¼body surface area
Table II. Comparison of the groups according to gender,
smoking habits, presence of hypertension, and dyslipidemia.
Uremic Group Nonuremic Group
(n¼ 30) (n¼ 26)
gender
male 16 (53.3%) 13 (50.0%)
female 14 (46.7%) 13 (50.0%)
smoking
 17 (56.7%) 14 (53.8%)
þ 13 (43.3%) 12 (46.2%)
hypertension
 9 (30%) 8 (30.8%)
þ 21 (70%) 18 (69.2%)
dyslipidemia
 19 (63.3%) 16 (61.5%)
þ 11 (36.7%) 10 (38.5%)
P is not significant for all findings.
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demonstrated that the carotid IMT of
HD patients was significantly
increased compared with that in the
general population.5 Also, a higher
prevalence of carotid artery lesions
was detected in HD patients by
Doppler echocardiography.13 HD
may accelerate atherosclerosis by
inducing an imbalance between
prooxidative and antioxidative
mechanisms, which may result from
loss of antioxidant substances via
dialysis and hemoincompatibility of
the dialysis system (membrane, dia-
lysis purity).12
It is not clear yet whether it is the
HD procedure or the uremia itself
that is the major determinant of the
increased risk of premature athero-
sclerosis. However, a high preva-
lence of carotid artery lesions was
even found in predialytic or renal
transplant patients.4 On the basis of
the results of these studies and ours,
Figure 1. Carotid intima-media thickness (IMT) in patients with uremia and
without uremia (controls).
Table III. Relationship of variables with carotid IMT by group.
Uremic Group Nonuremic Group
r p r p
age (yr) 0.34* <0.05 0.55{ <0.01
BMI 0.14 NS 0.10 NS
BSA 0.24 NS 0.04 NS
glucose 0.22 NS 0.15 NS
total cholesterol 0.10 NS 0.32 NS
triglyceride 0.40* <0.05 0.13 NS
total HDL cholesterol 1.12 NS 0.26 NS
total calcium 0.18 NS 0.11 NS
inorganic phosphorus 0.20 NS 0.29 NS
CaP product 0.21 NS 0.13 NS
systolic blood pressure 0.23 NS 0.33 NS
diastolic blood pressure 0.17 NS 0.32 NS
fibrinogen 0.15 NS 0.07 NS
cigarette (package-years) 0.02 NS 0.39 NS
hypertension duration (months) 0.13 NS 0.37 NS
*p<0.05
{p<0.01
Correlation analysis of variables with carotid IMT values, r¼ correlation coefficient
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we have concluded that it is likely
that it is uremic status per se, rather
than HD, that accelerates athero-
sclerosis.
A positive correlation was found
between age and carotid IMT both in
the patients with uremia and in the
controls. The aging of the uremic
population in the last decades seems
to have contributed to the high rate of
cardiovascular morbidity and mor-
tality. Studies in the general popula-
tion also have shown a positive
correlation between age and carotid
IMT.7,10,14
In our study, an association was
found between males and increased
carotid IMT in those with uremia,
whichwas consistentwith the results
of other studies.7,10 In patients with
end-stage renal failure, the preva-
lence of hypertension reaches 75%–
80% in the predialysis period.1 In our
study, 70% of the patients with
uremia and 69.2% of the control
subjects, who did not have uremia,
were hypertensive.
The 2 groups were similar in
presence of hypertension and sys-
tolic and diastolic blood pressures.
Nevertheless, the patients with ure-
mia had greater carotid IMT values
than did the controls. When hyper-
tensive and normotensive patients
were considered separately, patients
with uremia had higher carotid IMT
values than did controls, both among
those with hypertension and those
with normal blood pressure. No
correlation was found between sys-
tolic blood pressure, diastolic blood
pressure, duration of hypertension,
and carotid IMT. Therefore, the pre-
sence of hypertensionwas not shown
to affect carotid IMT values in either
group. This was consistent with the
results of some previous studies15,16
but not with others.3
On the basis of our findings, we
suggest that the effect of uremia on
early atherosclerosis may occur
through a mechanism other than
hypertension. Also, autonomic neu-
ropathy, which may lead to unstable
Table IV. Effect of categorical variables on carotid IMT.
Uremic Group Nonuremic Group
(n¼ 30) (n¼ 26)
gender
male 1.25 0.23a 1.04 0.17
female 1.08 0.11 1.02 0.14
dyslipidemia
 1.09 0.13 1.03 0.17
þ 1.31 0.22b,c 1.04 0.14
cigarettes
 1.14 0.19 1.00 0.12
þ 1.22 0.20 1.07 0.18
hypertension
 1.12 0.13d 0.98 0.15
þ 1.20 0.19e 1.06 0.15
The effect of categorically used variables on carotid IMT was analyzed with two- way ANOVA.
ap<0.05; uremic males vs. uremic females.
bp<0.05; uremics with dyslipidemia vs. uremics without dyslipidemia.
cp<0.01; uremics with dyslipidemia vs. nonuremics with dyslipidemia.
dp<0.05; uremics without hypertension vs. nonuremics without hypertension.
ep<0.05; uremics with hypertension vs. nonuremics with hypertension.
Table V. Risk factors affecting carotid IMT in the
uremic group.
B SB t p
triglycerides 0.0011 0.0004 2.26 <0.05
age 0.319 0.159 2.00 <0.05
B¼ regression coefficient; S¼ standard error; t¼ t-test statistics for B
Significant predictors of carotid IMT were investigated with multiple regression analysis. These
are the final results.
Table VI. Risk factors affecting carotid IMT in the
control group.
B SB t p
age 0.0088 0.0026 3.41 <0.01
B: regression coefficient; S¼ standard error; t¼ t-test statistics for B
Significant predictors of carotid IMT were investigated with multiple regression analysis. These
are the final results.
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blood pressure with uremia, might
have affected the results.17 However,
the similarity in blood pressure in
both groups at the time of testing
does not preclude the possibility of a
greater load of hypertension in the
group of patients with uremia over
time. A longitudinal study would
resolve this issue. An alternate pos-
sibility is that hypertension has a less
detrimental effect on carotid athero-
sclerosis in the presence of uremia.
In the present study, we did not
find any relation between smoking
and carotid IMT. Although several
studies8,14,18 have shown a strong
association between smoking and
carotid atherosclerosis, others have
not.1,16 BMI was found to be lower in
the patients with uremia than in the
controls. This may be a result of a
reduction in muscle mass because of
the impaired nutritional and physical
status that occurs with uremia.
The patients with uremia in our
study had higher fibrinogen levels.
Although fibrinogen has been shown
to be positively correlatedwith ather-
osclerosis,19 we did not find such a
relationship. The findings of other
studies indicated that hyperphospha-
temia and hyperparathyroidismwere
associated with atherosclerosis.20
However, we did not find such a
relationship of carotid IMT with
serum phosphorus level and Ca  P
product.
A significant association between
triglycerides and carotid IMT was
found in patients with uremia. Hy-
pertriglyceridemia is the most com-
mon lipid abnormality in uremia,
predominantly occurring because of
reduced catabolism of triglyceride-
rich lipoproteins and their remnants
including intermediate-density lipo-
protein (IDL). The relationship be-
tween hypertriglyceridemia and
atherosclerosis is not clear. Trigly-
ceride-rich lipoproteins and their
remnants have a high affinity to
macrophages; they convert them into
foam cells and thereby may enhance
the inflammatory reactions that
eventually result in vascular endo-
thelial cell damage and atheroscle-
rosis.21,22 Therefore, our findings
suggest that the role of triglyceride-
rich lipoproteins as an atherogenic
factor may be important in uremia.
Conclusion
Our findings indicate a greater risk of
premature atherosclerosis in patients
with uremia at the initiation of
chronic HD therapy than in those
without uremia but with a similar
cardiovascular risk profile. These
results may suggest that uremic
status has a unique influence on early
atherosclerosis. The association be-
tween triglyceride level and carotid
IMTin patients with uremia may
bring out the importance of triglycer-
ide-rich lipoproteins as an athero-
genic culprit and of the necessity for
therapeutic interventions to reduce
this risk factor.
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